| 康柏西普治疗老年性黄斑变性的研究现状 |
| |
| 引用本文： | 何海燕,陈子林. 康柏西普治疗老年性黄斑变性的研究现状[J]. 国际眼科杂志, 2015, 15(8): 1367-1369 |
| |
| 作者姓名： | 何海燕 陈子林 |
| |
| 作者单位： | 1. 汕头大学医学院, 中国广东省汕头市,515400
2. 516001,中国广东省惠州市中心人民医院眼科中心 |
| |
| 摘 要： | 老年性黄斑变性( AMD)已经成为发达国家老年人致盲的主要原因之一。随着AMD患者的逐年增加，这也成为眼科防盲研究中重要的课题之一。其病因并不完全清楚，但许多研究表明血管内皮生长因子( VEGF)在其发病中起了重要作用。随着抗VEGF药物的研发与应用，目前已有多种药物应用于该病，本文主要介绍康柏西普在老年性黄斑变性中的应用。
|
| 关 键 词： | 抗血管内皮生长因子药物 康柏西普 老年性黄斑变性 |
| 收稿时间： | 2015-04-21 |
| 修稿时间： | 2015-07-06 |
Research status of conbercept treating age-related macular degeneration |
| |
| Hai-Yan He and Zi-Lin Chen. Research status of conbercept treating age-related macular degeneration[J]. International Eye Science, 2015, 15(8): 1367-1369 |
| |
| Authors: | Hai-Yan He and Zi-Lin Chen |
| |
| Affiliation: | Medical College, Shantou Universtity, Shantou 515400, Guangdong Province, China;Ophthalmic Center, Huizhou Municipal Hospital, Huizhou 516001, Guangdong Province, China |
| |
| Abstract: | Age-related macular degeneration(AMD)is one of the major reasons of blindness among the elderly in the developed countries. As AMD patients are increasing year by year, AMD has become one of the important topics of ophthalmic research to prevent blindness. Its pathogenesis is not fully understood, but many studies have shown that vascular endothelial growth factor(VEGF)plays an important role in the pathogenesis. With the development and application of anti-VEGF drugs, there are a variety of drugs applied to the disease. This article introduces conbercept for the treatment of AMD. |
| |
| Keywords: | anti-vascular endothelial growth factor drugs conbercept age-related macular degeneration |
|
| 点击此处可从《国际眼科杂志》浏览原始摘要信息 |
|
点击此处可从《国际眼科杂志》下载全文 |
|
